BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 16324870)

  • 1. [Breast lobular carcinoma in situ: diagnosis and evolution].
    Espié M; Hocini H; Cuvier C; Giacchetti S; Bourstyn E; de Roquancourt A
    Gynecol Obstet Fertil; 2005 Dec; 33(12):964-9. PubMed ID: 16324870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current management of lobular carcinoma in situ of the breast.
    Osborne MP; Hoda SA
    Oncology (Williston Park); 1994 Feb; 8(2):45-9; discussion 49, 53-4. PubMed ID: 8167087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lobular carcinoma in situ of the breast].
    Llanos Muñoz M; Alonso Muñoz MC; Ojeda González B
    Med Clin (Barc); 1994 Oct; 103(14):553-6. PubMed ID: 7799670
    [No Abstract]   [Full Text] [Related]  

  • 4. The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ.
    Simpson PT; Gale T; Fulford LG; Reis-Filho JS; Lakhani SR
    Breast Cancer Res; 2003; 5(5):258-62. PubMed ID: 12927036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for women with lobular carcinoma in situ (LCIS).
    Oppong BA; King TA
    Oncology (Williston Park); 2011 Oct; 25(11):1051-6, 1058. PubMed ID: 22106556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lobular carcinoma in situ: current concepts and controversies.
    Schnitt SJ; Morrow M
    Semin Diagn Pathol; 1999 Aug; 16(3):209-23. PubMed ID: 10490198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobular neoplasia: morphology and management.
    Jorns J; Sabel MS; Pang JC
    Arch Pathol Lab Med; 2014 Oct; 138(10):1344-9. PubMed ID: 25268198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Carcinoma in situ. Prognostic factors].
    Trojani M
    Arch Anat Cytol Pathol; 1994; 42(5):234-50. PubMed ID: 7872815
    [No Abstract]   [Full Text] [Related]  

  • 9. Lobular carcinoma in situ.
    Afonso N; Bouwman D
    Eur J Cancer Prev; 2008 Aug; 17(4):312-6. PubMed ID: 18562954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobular carcinoma in situ (LCIS): pathology and treatment.
    Gump FE
    J Cell Biochem Suppl; 1993; 17G():53-8. PubMed ID: 8007710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer: a review of the literature.
    Richie RC; Swanson JO
    J Insur Med; 2003; 35(2):85-101. PubMed ID: 14733031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ and invasive lobular neoplasia of the breast.
    Hanby AM; Hughes TA
    Histopathology; 2008 Jan; 52(1):58-66. PubMed ID: 18171417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
    Chuba PJ; Hamre MR; Yap J; Severson RK; Lucas D; Shamsa F; Aref A
    J Clin Oncol; 2005 Aug; 23(24):5534-41. PubMed ID: 16110014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
    Aulmann S; Penzel R; Schirmacher P; Sinn HP
    Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-infiltrating breast cancers].
    Bosco V
    Chir Ital; 1998; 50(5-6):77-82. PubMed ID: 10392197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
    Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
    Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ductal carcinoma in situ of the breast].
    Rueda Domínguez A; Alonso Muñoz MC; Gómez Gómez A; Ojeda González B
    Med Clin (Barc); 1993 Oct; 101(14):548-56. PubMed ID: 8231402
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of lobular histology on breast cancer treatment.
    Hwang ES
    Oncology (Williston Park); 2011 Apr; 25(4):362, 364-5. PubMed ID: 21618959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.